产品名称 Eltoprazine hydrochloride - DU 28853
产品货号 Axon 1142 CAS [98206-09-8] MF C12H16N2O2.HClMW 256.73 Purity: 99% Soluble in water and DMSO Description 5-HT1A/1B agonist and 5-HT2C receptor antagonist. Following L-DOPA challenge, Eltoprazine causes a significant reduction of L-DOPA-induced dyskinesias. References Certificates Categories Extra info G Griebel et al. Serenics fluprazine (DU 27716) and eltoprazine (DU 28853) enhance neophobic and emotional behaviour in mice. Psychopharmacology 1990, 102, 498-502.   DR. Cherek et al. Acute effects of eltoprazine on aggression and point-mantained responding of normal male participants: Phase I study. Exp. Clin. Psychopharmacol. 1995, 3/3, 287-293.   P. Svenningsson et al. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Brain. 2015 Feb 10. pii: awu409. [Epub ahead of print] Certificate of Analysis Material Safety Data Sheet CNS 5-HT1A 5-HT1B 5-HT2C A19 5-HT1A and 5-HT1B agonist Chemical name 1-(2,3-Dihydro-benzo[1,4]dioxin-5-yl)-piperazine hydrochloride Parent CAS No. [98224-03-4] Order Size Unit Price Stock 10 mg €82.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Eltoprazine hydrochloride - DU 28853

Based on 14 reference(s) in Google Scholar 8 10 14

Axon 1142

CAS [98206-09-8]

MF C12H16N2O2.HCl
MW 256.73

  • Purity: 99%
  • Soluble in water and DMSO

Eltoprazine hydrochloride

Description

5-HT1A/1B agonist and 5-HT2C receptor antagonist. Following L-DOPA challenge, Eltoprazine causes a significant reduction of L-DOPA-induced dyskinesias.

产品资料